Who Owns PharmEasy? Current Ownership of API Holdings

PharmEasy is run by API Holdings Limited, the healthcare company that hosts the PharmEasy platform. But PharmEasy doesn't have a single owner. API Holdings has a number of institutional and individual shareholders including Naspers Ventures, MacRitchie Investments, TPG Growth and others.

The most recent audited ownership data filed by API Holdings is as of 31 March 2026. API Holdings has equity shares as well as compulsorily convertible preference shares (CCPS). The ownership percentages have to be read carefully and not just added up. 

Who Owns PharmEasy?

API Holdings Limited owns the PharmEasy brand and the proprietary technology that powers the PharmEasy marketplace. The PharmEasy marketplace itself is operated and managed by Axelia Solutions Private Limited, an associate company of API Holdings.

So when people talk about “PharmEasy ownership”, they are essentially referring to the ownership of API Holdings Limited.

Who Are the Largest Shareholders of API Holdings?

According to API Holdings' FY26 audited consolidated financial statements, the following shareholders held more than 5% of the company's equity shares as of March 31, 2026: 

Naspers Ventures was therefore the largest disclosed holder of API Holdings' equity shares, with an 11.58% stake as of March 31, 2026. 

What About TPG, Naspers and MacRitchie Preference Shares?

API Holdings also has compulsorily convertible preference shares (CCPS) too. These securities are convertible into equity shares and their ownership has to be considered separately.

As at 31 March 2026, the largest disclosed holders of CCPS Series A were MacRitchie Investments (34.50%), Naspers Ventures (34.50%), TPG Growth (18.40%) and CDPQ Private Equity Asia (10.34%). 

For CCPS Series B, the disclosed holders included:

These percentages are percentages of the respective preference-share class, not percentages of the entire company.

What Happened to MEMG and Ranjan Pai?

MEMG Family Office LLP was an important investor in API Holdings in earlier years.

However, it should not be described as a current major shareholder without a date qualifier.

API Holdings' FY26 financial statements show MEMG Family Office LLP at 0% of CCPS Series B as of March 31, 2026, compared with 21.81% a year earlier. During the same period, Claypond Capital Partners and 360 ONE Large Value Fund appeared as significant Series B holders. 

Separately, the Competition Commission of India recorded a transaction under which MEMG proposed transferring its existing stake in API Holdings to 360 ONE and Claypond Capital. The transaction involved stakes of up to 4.79% each in API Holdings. (CCI)

Is Ranjan Pai the Owner of PharmEasy?

No. It would be inaccurate to describe Ranjan Pai or MEMG as the owner of PharmEasy today.

API Holdings has been associated with Ranjan Pai and MEMG was a significant investor in the past but the company ownership is spread across a number of shareholders and investment vehicles. The latest audited filings reveal multiple significant equity and preference-share investors, rather than a single controlling shareholder. 

Who Founded PharmEasy?

PharmEasy was founded by a group of entrepreneurs including Siddharth Shah, Hardik Dedhia and Harsh Parekh.

Then API Holdings began to raise money from a few institutional investors. As the company grew and raised more money the founders got diluted.

That means founders, management and shareholders are not necessarily the same. I can be a founder or director but not the largest shareholder.

Is PharmEasy Owned by Tata, Reliance or Amazon?

No.

PharmEasy operates under API Holdings Limited. Its major disclosed shareholders include investors such as Naspers Ventures, MacRitchie Investments and TPG Growth, among others. There is no basis in the latest API Holdings filings for describing PharmEasy as owned by Tata, Reliance or Amazon. 

Who Owns the PharmEasy App?

The distinction between the PharmEasy brand and its marketplace operator is important.

API Holdings states that it owns the PharmEasy brand and proprietary technology. The PharmEasy marketplace is operated by Axelia Solutions Private Limited, which is an associate company of API Holdings.

This means the consumer-facing PharmEasy app and marketplace should not be treated as a separately listed or independently owned company.

Has PharmEasy Become Debt-Free?

Ownership and debt are separate issues.

API Holdings' FY26 annual report states that approximately ₹1,700 crore of debt from earlier lenders Goldman Sachs and Evox was replaced through NCDs issued to 360 ONE, with ₹620 crore of principal repaid during FY26. NCDs outstanding stood at approximately ₹1,080 crore as of March 31, 2026. 

Therefore, old articles describing the company's earlier Goldman Sachs debt position should not be presented as its current debt structure.

Conclusion

PharmEasy is not owned by one person.

The PharmEasy brand and technology are owned by API Holdings Limited and its associate Axelia Solutions is the operator of the PharmEasy marketplace. Naspers Ventures was the largest disclosed holder of API Holdings’ equity shares, holding 11.58% as of March 31, 2026, followed by MacRitchie Investments with 10.43% and TPG Growth with 6.40%. API Holdings also has large CCPS holdings among different investors.

Ownership has changed hands significantly over time including the transfer of MEMG’s former stake to 360 ONE and Claypond Capital. So, don’t assume that past rounds of funding are indicative of who owns the company today. (CCI)

Latest ownership reference:API Holdings Limited Annual Report 2025–26, with ownership information as of March 31, 2026.